ACTRN12613000387729已完成2 期
Adult patients with oesophageal-gastric cancer, to undergo an EUS guided fiducial insertion to mark the tumour in this phase II feasibility study for surgical pathological localisation and chemotherapy response assessment.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 99 Years(—)
- 性别
- All
入选标准
- •Age>18yrs with biopsy proven primary (non-recurrent) squamous cell carcinoma (SCC)or adenocarcinoma of the stomach discussed at the upper gastro-intestinal multidisciplinary team meeting (MDT) were considered eligible if they fulfilled the inclusion criteria. These criteria included cancer stage (T1-3,N0-1,M0-1a), ECOG 0 or 1, medically suitable for oeosphagectomy and chemotherapy and or chemoradiotherapy, and written informed consent.
排除标准
- •Contraindications to CT contrast e.g. severe chronic kidney disease, allergy to contrast
- •Contraindications to PET/CT e.g. claustrophobia
研究者
相似试验
进行中(未招募)
1 期
PLAnning Treatment For Oesophago-Gastric Cancer: a Randomised Maintenance Therapy TrialOesophago-gastric adenocarcinomaEUCTR2014-002169-30-GBThe Royal Marsden NHS Foundation Trust770
招募中
3 期
Management of advanced esophageal cancer patients received chemotherapy using early ctDNA dynamicsEsophageal cancerJPRN-UMIN000047559Division of Biomedical Research and Development, Institute of Biomedical Sciences, Iwate Medical University60
进行中(未招募)
不适用
Oesophageal squamous cell cancer: chemoradiotherapy versus chemotherapy and surgery - a feasibility study - Feasibility trial of chemoradiation or surgery for oesophageal canceroesophageal cancerMedDRA version: 12Level: LLTClassification code 10030151Term: Oesophageal cancerEUCTR2009-013877-16-GBniversity Hospitals Bristol NHS Foundation Trust
已完成
不适用
For advanced or recurrent esophageal cancer Of combination therapy - docetaxel-cisplatin-5 fluorouracil phase I/II trialAdvanced or recurrent esophageal cancerJPRN-UMIN000014625gifu University30
尚未招募
1 期
Juzendaihoto administration for esophageal cancer patientsEsophageal cancerJPRN-UMIN000036616agasaki University35
